Medigene is a biotechnology company founded in 1994 and is headquartered in Munich, Germany. The company focuses on creating treatment platforms to fight against different forms of cancer. They produce treatment platforms using the T cell, these 3 platforms are: TCR’s, DC’s & TABS. They have a partnership with bluebird bio, Inc. for the development of T cell receptors. They also create products for genital warts, solid tumours and autoimmune diseases.